The proposed bill would significantly update current statutes regarding the provision of abortion-inducing drugs by introducing new requirements for physicians. Under the new law, physicians would be mandated to conduct in-person examinations to verify pregnancy, assess blood type, and inform patients of potential side effects before administering the drugs. They must also document relevant medical information and ensure they are credentialed to manage complications or have a signed agreement with a qualified associate physician. A follow-up visit within 7 to 14 days post-abortion would be required to confirm the procedure's success and address any complications.

Additionally, the bill establishes civil relief provisions for violations of these new regulations, allowing affected individuals—including the woman who received the drug, a minor's parent, or the father of the unborn child—to file claims for damages related to psychological, emotional, and physical injuries. It also includes provisions for statutory damages and attorney fees, while ensuring the confidentiality of the patient's identity in legal proceedings. The legislation clarifies that it does not create or recognize a right to abortion and emphasizes the necessity of these requirements to protect the health and safety of pregnant women.

Statutes affected:
Introduced Version: 36-2160